Catalogue for Nurse

Qdenga^™▼

(dengue tetravalent vaccine (live, attenuated))

This page is intended for healthcare professionals.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.

For Prescribing Information please click GB or NI.

The Summary of Product Characteristics (SmPC) for Qdenga™ (dengue tetravalent vaccine (live, attenuated)) for GB is available on the eMC.

The Summary of Product Characteristics (SmPC) for Qdenga™ (dengue tetravalent vaccine (live, attenuated)) for NI is available on the eMC NI.

Therapeutic indications

Qdenga^TM▼(dengue tetravalent vaccine (live, attenuated)) is indicated for the prevention of dengue disease in individuals from 4 years of age. The use of Qdenga™ should be in accordance with official recommendations.

Information and resources listed on this page are provided by Takeda UK Ltd.

C-ANPROM/GB/DENV/0251 Date of preparation: September 2024

View other products in this catalogue

Sort by

List view | Grid view

Dengue Awareness Pull-Up Banner

Dengue awareness pull-up banner to be displayed in clinics to highlight dengue fever to potential eligible travellers.

Max quantity: 1

Quantity

Patient Leaflet

6 page DL patient leaflet.

Max quantity: 10

Quantity

Travel Badge

A badge for receptionist/pharmacist or any other relevant person working in a setting where a Travel Health service is offered. The badge is to encourage travellers to speak to a HCP about dengue fever and the potential risk on their travels.

Max quantity: 10

Quantity

Travel Vaccination Logbook

A vaccination logbook for travellers to document their travel vaccinations.

Max quantity: 100

Quantity

Vaccination Reminder Card

2 page pocket-sized vaccination reminder card.

Max quantity: 10

Quantity

Sort by

List view | Grid view

Showing 5 of 5 materials